Cheryl L. Cohen
Ms. Cohen has served as a member of the Board of Directors of Novus Therapeutics, Inc. (formerly Tokai Pharmaceuticals, Inc.) since April 2015. Ms. Cohen previously served as Chief Commercial Officer of Medivation, Inc. from 2011 to 2014. Ms. Cohen currently serves as President of CLC Consulting, a pharmaceutical and biotechnology consulting firm specializing in new product start-up and commercialization, where she also served as President from 2008 to 2011. Ms. Cohen also served as Vice President, Strategic Commercial Group, of Health Care Systems, Inc., a Johnson & Johnson company from 1998 to 2007, she worked at Janssen Biotech, Inc. (formerly Centocor Biotech, Inc.), a Johnson & Johnson company, in a variety of senior sales roles including Vice President, Rheumatology Franchise. Ms. Cohen began her career at Solvay Pharmaceuticals in a variety of sales positions. Ms. Cohen currently serves on the boards of directors of Protein Sciences Corp., a private company, and Vital Therapies, Inc., a publicly-traded company. Ms. Cohen received her B.A. from Saint Joseph College.